Scalp psoriasis causes red, purple, or brown patches with silvery scales. Medicated shampoos and topical medicines can help manage scalp psoriasis. Stress and inflammation can cause hair loss in ...

Guselkumab demonstrated strong efficacy in treating moderate to severe scalp psoriasis, especially in individuals with skin of color, achieving nearly 70% complete scalp clearance by week 48. The ...

Dealing with psoriasis can be difficult and stressful — but there are ways to manage this autoimmune condition on your own. For example, if you have psoriasis on your scalp, using the right shampoo ...

Dandruff is one skin issue many of us are quick to self-diagnose. Not just because the symptoms seem obvious, but because we’re frequently hit with marketing for the latest, greatest treatment options ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Significantly more patients treated with Tremfya vs.

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Here’s our process. Psoriasis is an immune-mediated, chronic ...

If you think you may have scalp psoriasis—a subtype of plaque psoriasis—getting an official diagnosis is so important, even if your symptoms seem mild and “not a big deal.” Not only can psoriasis ...

Skin conditions can be extremely challenging to navigate. People experiencing conditions like scalp psoriasis often find that they're hyperaware of ingredient lists and chemicals, all in an effort to ...

Fed up with flakes on your shoulders and an itchy scalp that just won't settle? Before you buy yet another shampoo, here's ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Roflumilast foam 0.3% is a formulation that can treat ...

Credit: Arcutis. The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis ...

A two-year Japanese real-world study of 66 patients shows the dual IL-17A and IL-17F inhibitor bimekizumab sustained high ...